Cargando…
Gut Microbiota Alteration and Its Modulation with Probiotics in Celiac Disease
Celiac disease (CD) is a chronic inflammation of the small intestine triggered by gluten ingestion in genetically predisposed people. Recent literature studies highlight the possible role of the gut microbiota in the pathogenesis of this disease. The gut microbiota is a complex community of microorg...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603901/ https://www.ncbi.nlm.nih.gov/pubmed/37893012 http://dx.doi.org/10.3390/biomedicines11102638 |
_version_ | 1785126706860785664 |
---|---|
author | Saviano, Angela Petruzziello, Carmine Brigida, Mattia Morabito Loprete, Maria Rita Savioli, Gabriele Migneco, Alessio Ojetti, Veronica |
author_facet | Saviano, Angela Petruzziello, Carmine Brigida, Mattia Morabito Loprete, Maria Rita Savioli, Gabriele Migneco, Alessio Ojetti, Veronica |
author_sort | Saviano, Angela |
collection | PubMed |
description | Celiac disease (CD) is a chronic inflammation of the small intestine triggered by gluten ingestion in genetically predisposed people. Recent literature studies highlight the possible role of the gut microbiota in the pathogenesis of this disease. The gut microbiota is a complex community of microorganisms that can interact with the innate and adaptative immune systems. A condition of dysbiosis, which refers to an alteration in the composition and function of the human gut microbiota, can lead to a dysregulated immune response. This condition may contribute to triggering gluten intolerance, favoring the development and/or progression of CD in genetically susceptible patients. Interestingly, studies on children and adults with CD showed a different microbiome profile in fecal samples, with a different degree of “activity” for the disease. From this point of view, our review aimed to collect and discuss modern evidence about the alteration of the gut microbiota and its modulation with probiotics, with possible future indications in the management of patients affected by CD. |
format | Online Article Text |
id | pubmed-10603901 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106039012023-10-28 Gut Microbiota Alteration and Its Modulation with Probiotics in Celiac Disease Saviano, Angela Petruzziello, Carmine Brigida, Mattia Morabito Loprete, Maria Rita Savioli, Gabriele Migneco, Alessio Ojetti, Veronica Biomedicines Review Celiac disease (CD) is a chronic inflammation of the small intestine triggered by gluten ingestion in genetically predisposed people. Recent literature studies highlight the possible role of the gut microbiota in the pathogenesis of this disease. The gut microbiota is a complex community of microorganisms that can interact with the innate and adaptative immune systems. A condition of dysbiosis, which refers to an alteration in the composition and function of the human gut microbiota, can lead to a dysregulated immune response. This condition may contribute to triggering gluten intolerance, favoring the development and/or progression of CD in genetically susceptible patients. Interestingly, studies on children and adults with CD showed a different microbiome profile in fecal samples, with a different degree of “activity” for the disease. From this point of view, our review aimed to collect and discuss modern evidence about the alteration of the gut microbiota and its modulation with probiotics, with possible future indications in the management of patients affected by CD. MDPI 2023-09-26 /pmc/articles/PMC10603901/ /pubmed/37893012 http://dx.doi.org/10.3390/biomedicines11102638 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Saviano, Angela Petruzziello, Carmine Brigida, Mattia Morabito Loprete, Maria Rita Savioli, Gabriele Migneco, Alessio Ojetti, Veronica Gut Microbiota Alteration and Its Modulation with Probiotics in Celiac Disease |
title | Gut Microbiota Alteration and Its Modulation with Probiotics in Celiac Disease |
title_full | Gut Microbiota Alteration and Its Modulation with Probiotics in Celiac Disease |
title_fullStr | Gut Microbiota Alteration and Its Modulation with Probiotics in Celiac Disease |
title_full_unstemmed | Gut Microbiota Alteration and Its Modulation with Probiotics in Celiac Disease |
title_short | Gut Microbiota Alteration and Its Modulation with Probiotics in Celiac Disease |
title_sort | gut microbiota alteration and its modulation with probiotics in celiac disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603901/ https://www.ncbi.nlm.nih.gov/pubmed/37893012 http://dx.doi.org/10.3390/biomedicines11102638 |
work_keys_str_mv | AT savianoangela gutmicrobiotaalterationanditsmodulationwithprobioticsinceliacdisease AT petruzziellocarmine gutmicrobiotaalterationanditsmodulationwithprobioticsinceliacdisease AT brigidamattia gutmicrobiotaalterationanditsmodulationwithprobioticsinceliacdisease AT morabitolopretemariarita gutmicrobiotaalterationanditsmodulationwithprobioticsinceliacdisease AT savioligabriele gutmicrobiotaalterationanditsmodulationwithprobioticsinceliacdisease AT mignecoalessio gutmicrobiotaalterationanditsmodulationwithprobioticsinceliacdisease AT ojettiveronica gutmicrobiotaalterationanditsmodulationwithprobioticsinceliacdisease |